RT Journal Article
SR Electronic
A1 Cunningham, Muriel
T1 Update on the MISTIE Trial
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 1
SP 10
OP 10
DO 10.1177/155989770800800104
UL http://mdc.sagepub.com/content/8/1/10.1.abstract
AB Intracerebral hemorrhage (ICH) mortality estimates range from 37% (STICH trial) to 56% (SCHIPA trial). The Minimally Invasive Surgery plus t-PA for Intracerebral Hemorrhage Evacuation [MISTIE] trial was a phase 2 study sponsored by the National Institute of Neurological Disease and Stroke. The objective of the study was to determine whether reduction of clot size in ICH leads to lower mortality and better outcomes for patients.